A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

A Swedish-led study validated a self-administered digital cognitive test (BioCog) in primary care, showing it can accurately ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

La Jolla researchers say there is a pressing need for cost-effective tests for markers of Alzheimer’s disease and related dementia in groups considered underrepresented in studies — particularly ...

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. "This digital test, which patients perform ...

Scientists have designed a new cognitive test that diagnoses patients more accurately with Alzheimer's. The digital test times how long it takes patients to remember objects and make word associations ...